Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genome-wide association study of hospitalized patients and acute kidney injury.
Siew ED, Hellwege JN, Hung AM, Birkelo BC, Vincz AJ, Parr SK, Denton J, Greevy RA, Robinson-Cohen C, Liu H, Susztak K, Matheny ME, Velez Edwards DR. Siew ED, et al. Among authors: matheny me. Kidney Int. 2024 Aug;106(2):291-301. doi: 10.1016/j.kint.2024.04.019. Epub 2024 May 24. Kidney Int. 2024. PMID: 38797326
Heart failure subtype after acute kidney injury.
Birkelo BC, Brittain E, Guide A, Greevy RA, Matheny ME, Annis J, Richardson T, Faubel S, Siew ED. Birkelo BC, et al. Among authors: matheny me. BMC Nephrol. 2024 May 17;25(1):167. doi: 10.1186/s12882-024-03602-1. BMC Nephrol. 2024. PMID: 38760794 Free PMC article.
Documented Adverse Drug Reactions and Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Chronic Kidney Disease.
Gregg LP, Richardson PA, Herrera MA, Akeroyd JM, Jafry SA, Gobbel GT, Wydermyer S, Arney J, Hung A, Matheny ME, Virani SS, Navaneethan SD. Gregg LP, et al. Among authors: matheny me. Am J Nephrol. 2023;54(3-4):126-135. doi: 10.1159/000530988. Epub 2023 May 18. Am J Nephrol. 2023. PMID: 37231800 Free PMC article.
Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM.
Khera R, Dhingra LS, Aminorroaya A, Li K, Zhou JJ, Arshad F, Blacketer C, Bowring MG, Bu F, Cook M, Dorr DA, Duarte-Salles T, DuVall SL, Falconer T, French TE, Hanchrow EE, Horban S, Lau WC, Li J, Liu Y, Lu Y, Man KK, Matheny ME, Mathioudakis N, McLemore MF, Minty E, Morales DR, Nagy P, Nishimura A, Ostropolets A, Pistillo A, Posada JD, Pratt N, Reyes C, Ross JS, Seager S, Shah N, Simon K, Wan EY, Yang J, Yin C, You SC, Schuemie MJ, Ryan PB, Hripcsak G, Krumholz H, Suchard MA. Khera R, et al. Among authors: matheny me. BMJ Med. 2023 Oct 6;2(1):e000651. doi: 10.1136/bmjmed-2023-000651. eCollection 2023. BMJ Med. 2023. PMID: 37829182 Free PMC article.
222 results